Previous close | 231.01 |
Open | 230.74 |
Bid | 232.46 x 1100 |
Ask | 232.61 x 1100 |
Day's range | 229.40 - 232.64 |
52-week range | 229.40 - 287.32 |
Volume | |
Avg. volume | 1,366,950 |
Market cap | 67.086B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 53.14 |
EPS (TTM) | 4.37 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 3.80 (1.64%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | 278.54 |
BD's (BDX) slew of product launches and strategic deals raises optimism about the stock.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.
The latest worldwide commercial availability of BD's (BDX) cell sorters is set to expand researchers' capabilities to transform research and cell-based therapeutic development across numerous fields.